Loading...
Oddity Tech delivered a robust Q3 2025, beating expectations on revenue, adjusted EBITDA, and adjusted EPS. Net income remained flat year-over-year, but gross margin expanded. The quarter also featured the official launch of METHODIQ, their new medical brand.
Oddity raised its full-year 2025 outlook on stronger-than-expected Q3 results and a positive start to Q4.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance